A Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of C16TR for Inhalation With Tyvaso® Cohort in Healthy Participants

Status:
Completed

Trial end date:
2015-12-18

Target enrollment:

Participant gender:

The primary purpose of this study is to determine the safety and tolerability of escalating doses of C16TR for inhalation in healthy participants.

Phase 1

Insmed Incorporated

Treprostinil